Evidence map›Paper›PMID 12654820›Full record

ArticleInfection and immunity2003

Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice.

Tor A Strand, Susan K Hollingshead, Kåre Julshamn, David E Briles, Bjørn Blomberg, Halvor Sommerfelt

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00252304 (Efficacy of Zinc as Adjuvant Therapy in the Treatment of Severe Pneumonia in Nepalese Children at the Kanti Children's Hospital), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00252304 phase2 / phase3completednot on this mapstarted 2006, after this paper: background citation

Efficacy of Zinc as Adjuvant Therapy in the Treatment of Severe Pneumonia in Nepalese Children at the Kanti Children's Hospital

TypeinterventionalSponsorCentre For International HealthRan2006 to 2008Enrolled641ConditionsPneumoniaArmsZinc (zinc sulphate), Placebo
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. The global proteome ofFrontiers in cellular and infection microbiology · 2025
    Article
  3. Article
  4. TheMicrobiology spectrum · 2023
    Article
  5. Article
  6. Article
  7. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review).International journal of molecular medicine · 2020
    Review
  8. Article
  9. Article
  10. Transition Metals and Virulence in Bacteria.Annual review of genetics · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Alcohol abuse, the alveolar macrophage and pneumonia.The American journal of the medical sciences · 2012
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tor A StrandCentre for International Health and Department of Microbiology and Immunology, The Gade Institute, University of Bergen, Bergen N-5021, Norway. Tor.Strand@cih.uib.no
Susan K Hollingshead
Kåre Julshamn
David E Briles
Bjørn Blomberg
Halvor Sommerfelt
University of Bergen · NOUniversity of Alabama at Birmingham · USDirectorate of Fisheries · NO

Funding

PspA: A Potential Pneumococcal Vaccine ComponentR01AI021548 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRILES, DAVID E · 1985 to 2012
$6.0M
PspA mechanisms of humoral immunity, functional assays, and optimal vaccine constR56AI021548 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRILES, DAVID E · 2014 to 2014
$543k
NIAID NIH HHS AI 21548NIAID NIH HHS R01 AI021548NIAID NIH HHS R56 AI021548
6 · The paper itself

Abstract

Streptococcus pneumoniae is a major cause of illness and death in children in developing countries. In these children, zinc deficiency is associated with an increased risk of acute respiratory tract infections, which can be reduced by daily zinc administration. Severe infections decrease zinc levels in plasma and may thereby move individuals with preexisting low zinc stores into a vicious cycle of infection and unavailable zinc. Pneumococcal surface protein A (PspA) has emerged as a promising vaccine candidate, and immunization with this antigen protects animals from pneumococcal infection. In an animal experiment, we measured the effect of zinc depletion on the immune response to parenterally administrated PspA and assessed the effect of this PspA vaccination and zinc depletion on the severity of pneumococcal infection and on zinc status. Mice were kept on different diets for 5 weeks, immunized twice 14 days apart, and challenged intranasally with S. pneumoniae. Mice on the zinc-deficient diet showed substantially reduced immune responses to PspA, more extensive pneumococcal colonization in the nasal mucosa, more severe infections, and an increased risk of death. PspA immunization reduced the risk of severe disease, and the reduction in severity was reflected in substantially reduced zinc depletion from bones.

Indexed as

AnimalsBacteremiaBacterial ProteinsDisease Models, AnimalFemaleMiceMice, Inbred BALB CNasal MucosaPneumococcal InfectionsPneumococcal VaccinesSeverity of Illness IndexStreptococcus pneumoniaeVaccinationZincBacterial Proteinspneumococcal surface protein APneumococcal VaccinesZinc

Identifiers

PMID12654820
PMCPMC152078
OpenAlexW2168248136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.